• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲队列中接受法洛四联症修复术患者的长期生存情况及非自然死亡情况

Long-term survival and unnatural deaths of patients with repaired tetralogy of Fallot in an Asian cohort.

作者信息

Chiu Shuenn-Nan, Wang Jou-Kou, Chen Hui-Chi, Lin Ming-Tai, Wu En-Ting, Chen Chun-An, Huang Shu-Chien, Chang Chung-I, Chen Yih-Sharng, Chiu Ing-Sh, Chen Chi-Ling, Wu Mei-Hwan

机构信息

Department of Pediatrics, National Taiwan University Hospital and Medical College, National Taiwan University, Taipei, Taiwan.

出版信息

Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):120-5. doi: 10.1161/CIRCOUTCOMES.111.963603. Epub 2012 Jan 10.

DOI:10.1161/CIRCOUTCOMES.111.963603
PMID:22235069
Abstract

BACKGROUND

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease in Taiwan. This study investigates the long-term survival and risks of TOF in an Asian cohort.

METHODS AND RESULTS

This study enrolled 819 consecutive patients with TOF (61.1% male), who received total correction between 1970 and 2002, as participants. Patient medical records were reviewed, and the survival status of those out of contact was confirmed by death records retrieved from the National Health database. The mean (±SD) patient age at cardiac repair was 6.5±7.6 years, and a prior shunt operation was performed in 119 (14.5%) of the patients. At cardiac repair, a transannular patch for right ventricle outlet reconstruction was required in 444 (54.2%) of the patients. After 13,808 patient-years of follow-up, the 30-year survival rate was 90.5%. The annual mortality rate increased from 0.123% in the initial 15 years after repair to 0.395% thereafter (P<0.05). The presence of major aortopulmonary collateral arteries, older operative age, and previous shunt operation are independent risks of late cardiac deaths. Secondary to cardiac mortality, unnatural deaths (accident and suicide) accounted for 27.6% of late deaths, significantly higher compared with that of the general population (odds ratio, 2.18; P=0.028).

CONCLUSIONS

In this Asian TOF cohort, except for a late decrease after 15 years, long-term survival after cardiac repair was satisfactory. Although cardiac death was the most common cause of late death, accidents or suicide may also be associated with late mortality, suggesting a potential role for psychosocial support.

摘要

背景

法洛四联症(TOF)是台湾最常见的青紫型先天性心脏病。本研究调查了亚洲队列中TOF患者的长期生存情况及风险。

方法与结果

本研究纳入了1970年至2002年间连续接受根治手术的819例TOF患者(男性占61.1%)作为研究对象。回顾患者病历,并通过从国民健康数据库检索到的死亡记录确认失访患者的生存状态。心脏修复时患者的平均(±标准差)年龄为6.5±7.6岁,119例(14.5%)患者曾接受过分流手术。心脏修复时,444例(54.2%)患者需要使用跨环补片进行右心室流出道重建。经过13808患者年的随访,30年生存率为90.5%。年死亡率从修复后的最初15年的0.123%增加到此后的0.395%(P<0.05)。存在主要的主肺动脉侧支血管、手术年龄较大和既往分流手术是晚期心脏死亡的独立危险因素。除心脏原因导致的死亡外,非自然死亡(意外和自杀)占晚期死亡的27.6%,显著高于一般人群(优势比,2.18;P=0.028)。

结论

在这个亚洲TOF队列中,除了15年后生存率有所下降外,心脏修复后的长期生存情况令人满意。虽然心脏死亡是晚期死亡最常见的原因,但意外或自杀也可能与晚期死亡率相关,提示心理社会支持可能发挥潜在作用。

相似文献

1
Long-term survival and unnatural deaths of patients with repaired tetralogy of Fallot in an Asian cohort.亚洲队列中接受法洛四联症修复术患者的长期生存情况及非自然死亡情况
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):120-5. doi: 10.1161/CIRCOUTCOMES.111.963603. Epub 2012 Jan 10.
2
Need of transannular patch in tetralogy of Fallot surgery carries a higher risk of reoperation but has no impact on late survival: results of Fallot repair in Finland.法洛四联症手术中使用经环补片会增加再次手术风险,但对远期生存率无影响:芬兰法洛四联症修复手术结果
Eur J Cardiothorac Surg. 2015 Jul;48(1):91-7. doi: 10.1093/ejcts/ezu401. Epub 2014 Oct 17.
3
Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium.法洛四联症的长期预后:儿科心脏护理联合会的一项研究。
JAMA Cardiol. 2019 Jan 1;4(1):34-41. doi: 10.1001/jamacardio.2018.4255.
4
Early and late outcomes of total repair of tetralogy of Fallot: risk factors for late right ventricular dilatation.法洛四联症全修复术的早期和晚期结果:晚期右心室扩张的危险因素。
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):956-62. doi: 10.1093/icvts/ivt361. Epub 2013 Aug 15.
5
Long-term survival after repair of tetralogy of Fallot.
J Insur Med. 2000;32(2):89-92.
6
Mortality and risk factors for late deaths in tetralogy of Fallot: the Japanese Nationwide Multicentric Survey.法洛四联症晚期死亡的死亡率及危险因素:日本全国多中心调查
Cardiol Young. 2002 Oct;12(5):453-60. doi: 10.1017/s104795110200077x.
7
Surgical repair of tetralogy of Fallot. Long-term follow-up with particular emphasis on late death and reoperation.法洛四联症的外科修复。长期随访,特别关注晚期死亡和再次手术情况。
J Thorac Cardiovasc Surg. 1985 Feb;89(2):204-20.
8
Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up.右心室流出道重建同种异体管道患者法洛四联症矫正后:长期随访。
Ann Thorac Surg. 2011 Jul;92(1):161-6. doi: 10.1016/j.athoracsur.2011.02.036. Epub 2011 May 18.
9
A first population-based long-term outcome study in adults with repaired tetralogy of Fallot in Malta.在马耳他进行的第一项针对法洛四联症修复术后成人的基于人群的长期结局研究。
Congenit Heart Dis. 2017 May;12(3):301-308. doi: 10.1111/chd.12439. Epub 2016 Nov 28.
10
Outcome after repair of atrioventricular septal defect with tetralogy of Fallot.法洛四联症合并房室间隔缺损的修复术后结果。
J Thorac Cardiovasc Surg. 2012 Feb;143(2):338-43. doi: 10.1016/j.jtcvs.2011.05.031. Epub 2011 Sep 8.

引用本文的文献

1
Clinical Outcome Prediction Model in Tetralogy of Fallot Without Pulmonary Valve Replacement Using Contraction Fraction From the SCOUT-TOF Registry.使用SCOUT-TOF注册研究中的收缩分数对法洛四联症患者不进行肺动脉瓣置换术的临床结局预测模型
J Am Heart Assoc. 2025 May 20;14(10):e037983. doi: 10.1161/JAHA.124.037983. Epub 2025 May 13.
2
Cardiovascular magnetic resonance in Tetralogy of Fallot-state of the art.法洛四联症的心血管磁共振成像——最新技术
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):173-194. doi: 10.21037/cdt-24-378. Epub 2025 Feb 25.
3
Mental health in adult congenital heart disease.
成人先天性心脏病中的心理健康
Int J Cardiol Congenit Heart Dis. 2023 Apr 1;12:100455. doi: 10.1016/j.ijcchd.2023.100455. eCollection 2023 Jun.
4
Pulmonary and tricuspid regurgitation after Tetralogy of Fallot repair: A case report.法洛四联症修复术后的肺动脉和三尖瓣反流:一例报告。
World J Cardiol. 2023 Dec 26;15(12):642-648. doi: 10.4330/wjc.v15.i12.642.
5
Considerations in Timing of Surgical Repair in Tetralogy of Fallot.法洛四联症手术修复时机的考量
CJC Pediatr Congenit Heart Dis. 2023 Oct 16;2(6Part A):361-367. doi: 10.1016/j.cjcpc.2023.10.006. eCollection 2023 Dec.
6
Survival Trends in Children With Tetralogy of Fallot in Sweden From 1970 to 2017.瑞典 1970 年至 2017 年法洛四联症患儿的生存趋势。
JAMA Netw Open. 2023 May 1;6(5):e2314504. doi: 10.1001/jamanetworkopen.2023.14504.
7
Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.美国心脏协会认可的心血管磁共振学会/欧洲心血管成像学会/美国超声心动图学会/儿科放射学会/北美心血管成像学会在儿科先天性和获得性心脏病中使用心脏磁共振指南
Circ Cardiovasc Imaging. 2022 Jun;15(6):e014415. doi: 10.1161/CIRCIMAGING.122.014415. Epub 2022 Jun 21.
8
Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.中华医学会心血管病学分会精准心血管医学学组专家共识 ——人工智能在心血管疾病中的临床应用
J Cardiovasc Magn Reson. 2022 Jun 21;24(1):37. doi: 10.1186/s12968-022-00843-7.
9
Ventricular Myocardial Deformation in Fetuses With Tetralogy of Fallot: A Necessary Field of Investigation.法洛四联症胎儿的心室心肌变形:一个必要的研究领域。
Front Cardiovasc Med. 2021 Dec 10;8:764676. doi: 10.3389/fcvm.2021.764676. eCollection 2021.
10
Tetralogy of Fallot in the nascent open-heart surgical era in a tertiary hospital in south-west Nigeria: lessons learnt.尼日利亚西南部一家三级医院在心脏直视手术初期时代的法洛四联症:经验教训。
Cardiovasc J Afr. 2022;33(3):122-126. doi: 10.5830/CVJA-2021-048. Epub 2021 Nov 22.